| Literature DB >> 20003397 |
Hui Li1, Cheng-Ye Wang, Jia-Xin Wang, Nelson Leung-Sang Tang, Liang Xie, Yuan-Ying Gong, Zhao Yang, Liang-You Xu, Qing-Peng Kong, Ya-Ping Zhang.
Abstract
BACKGROUND: DC-SIGNR (also called CD209L) has been extensively studied on its role in host genetic predisposition to viral infection. In particular, variable number tandem repeat (VNTR) of the neck-region of DC-SIGNR is highly polymorphic and the polymorphism has been investigated for genetic predisposition to various infectious diseases, though conflicting results had been reported. As infection is a major cause of human death and a mechanism of natural selection, we hypothesized that VNTR polymorphism of DC-SIGNR might have an effect on human life span.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20003397 PMCID: PMC2797785 DOI: 10.1186/1471-2350-10-134
Source DB: PubMed Journal: BMC Med Genet ISSN: 1471-2350 Impact factor: 2.103
Genotype, allele distribution and homozygote proportion of DC-SIGNR neck region in peri-centenarian and control group.
| Peri-centenarian | Controls | ||||
|---|---|---|---|---|---|
| Genotype | (N = 361) | (N = 342) | |||
| 5/5 | 9 | 2.49% | 10 | 2.92% | 0.082 |
| 5/6 | 3 | 0.83% | 5 | 1.46% | 0.495 |
| 5/7 | 70 | 19.39% | 73 | 21.35% | 0.574 |
| 5/9 | 15 | 4.16% | 14 | 4.09% | 1.000 |
| 6/6 | 2 | 0.55% | 0 | 0.00% | 0.500 |
| 6/7 | 15 | 4.16% | 15 | 4.39% | 1.000 |
| 6/9 | 3 | 0.83% | 6 | 1.75% | 0.329 |
| 7/7 | 165 | 45.71% | 151 | 44.15% | 0.705 |
| 7/8 | 0 | 0.00% | 1 | 0.29% | 0.486 |
| 7/9 | 70 | 19.39% | 61 | 17.84% | 0.629 |
| 9/9 | 9 | 2.49% | 6 | 1.75% | 0.605 |
| homozygotes | 185 | 51.25% | 167 | 48.83% | 0.546 |
| heterozygotes | 176 | 48.75% | 175 | 51.17% | 0.546 |
| Alleles | |||||
| 5 | 106 | 14.68% | 112 | 16.37% | 0.418 |
| 6 | 25 | 3.46% | 26 | 3.80% | 0.776 |
| 7 | 485 | 67.17% | 452 | 66.08% | 0.692 |
| 8 | 0 | 0.00% | 1 | 0.15% | 0.486 |
| 9 | 106 | 14.68% | 93 | 13.60% | 0.592 |
Genotype, allele distribution and homozygote proportion of DC-SIGNR neck region in peri-centenarian and control group stratified by gender.
| Peri-centenarian Female | Controls Female | Peri-centenarian Male | Control | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Genotype | N = 180 | N = 156 | N = 181 | N = 186 | ||||||
| 5/5 | 1 | 0.56% | 6 | 3.85% | 0.053 | 8 | 4.42% | 4 | 2.15% | 0.253 |
| 5/6 | 1 | 0.56% | 3 | 1.92% | 0.341 | 2 | 1.10% | 2 | 1.08% | 1.000 |
| 5/7 | 29 | 16.11% | 32 | 20.51% | 0.322 | 41 | 22.65% | 41 | 22.04% | 0.901 |
| 5/9 | 8 | 4.44% | 3 | 1.92% | 0.232 | 7 | 3.87% | 11 | 5.91% | 0.470 |
| 6/6 | 2 | 1.11% | 0 | 0.00% | 0.501 | 0 | 0.00% | 0 | 0.00% | nc |
| 6/7 | 10 | 5.56% | 2 | 1.28% | 0.041 | 5 | 2.76% | 13 | 6.99% | 0.089 |
| 6/9 | 2 | 1.11% | 3 | 1.92% | 0.666 | 1 | 0.55% | 3 | 1.61% | 0.623 |
| 7/7 | 83 | 46.11% | 74 | 47.44% | 0.827 | 82 | 45.30% | 77 | 41.40% | 0.463 |
| 7/8 | 0 | 0.0% | 1 | 0.64% | 0.464 | 0 | 0.00% | 0 | 0.00% | nc |
| 7/9 | 41 | 22.78% | 29 | 18.59% | 0.419 | 29 | 19.02% | 32 | 17.20% | 0.781 |
| 9/9 | 3 | 1.67% | 3 | 1.92% | 1.000 | 6 | 3.31% | 3 | 1.61% | 0.332 |
| homozygotes | 89 | 49.45% | 83 | 53.21% | 0.513 | 96 | 53.04% | 84 | 45.16% | 0.144 |
| Heterozygotes | 91 | 50.55% | 73 | 46.79% | 0.513 | 85 | 46.96% | 102 | 54.84% | 0.144 |
| Alleles | ||||||||||
| 5 | 40 | 11.11% | 50 | 16.03% | 0.069 | 66 | 18.23% | 62 | 16.67% | 0.627 |
| 6 | 17 | 4.72% | 8 | 2.56% | 0.157 | 8 | 2.21% | 18 | 4.84% | 0.071 |
| 7 | 246 | 68.33% | 212 | 67.95% | 0.934 | 239 | 66.02% | 240 | 64.52% | 0.699 |
| 8 | 0 | 0.00% | 1 | 0.32% | 0.464 | 0 | 0.00% | 0 | 0.00% | nc |
| 9 | 57 | 15.83% | 41 | 13.14% | 0.381 | 49 | 13.54% | 52 | 13.98% | 0.915 |
Abbreviation: nc, not calculated.